Page 1

oasmia ACQUISITION OF GLOBAL DEVELOPMENT AND COMMERCIALIZATION RIGHTS FOR CANTRIXIL , A CLINICAL STAGE OVARIAN CANCER PROGRAM Building critical mass in the oncology pipeline FRANCOIS MARTELET , M.D. , Chief Executive Officer REINHARD KOENIG , M.D. , Acting Chief Scientific Officer 1 March 2021